BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8946274)

  • 1. ATL and HTLV-I: in vivo cell growth of ATL cells.
    Uchiyama T
    J Clin Immunol; 1996 Nov; 16(6):305-14. PubMed ID: 8946274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OX40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: implication for the possible involvement of OX40 in leukemic cell infiltration.
    Imura A; Hori T; Imada K; Kawamata S; Tanaka Y; Imamura S; Uchiyama T
    Blood; 1997 Apr; 89(8):2951-8. PubMed ID: 9108415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells.
    Imura A; Hori T; Imada K; Ishikawa T; Tanaka Y; Maeda M; Imamura S; Uchiyama T
    J Exp Med; 1996 May; 183(5):2185-95. PubMed ID: 8642328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of in vivo cell proliferation of ATL using SCID mice].
    Imada K; Takaori-Kondo A; Uchiyama T
    Rinsho Ketsueki; 1995 Jun; 36(6):573-7. PubMed ID: 7643453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34.
    Baum PR; Gayle RB; Ramsdell F; Srinivasan S; Sorensen RA; Watson ML; Seldin MF; Baker E; Sutherland GR; Clifford KN
    EMBO J; 1994 Sep; 13(17):3992-4001. PubMed ID: 8076595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of OX40, a receptor of gp34, on T cells by trans-acting transcriptional activator, Tax, of human T-cell leukemia virus type I.
    Higashimura N; Takasawa N; Tanaka Y; Nakamura M; Sugamura K
    Jpn J Cancer Res; 1996 Mar; 87(3):227-31. PubMed ID: 8613423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T cell leukemia virus type I (HTLV-I) and human diseases.
    Uchiyama T
    Annu Rev Immunol; 1997; 15():15-37. PubMed ID: 9143680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumorigenicity of human T-cell leukemia virus type I-infected cell lines in severe combined immunodeficient mice and characterization of the cells proliferating in vivo.
    Imada K; Takaori-Kondo A; Akagi T; Shimotohno K; Sugamura K; Hattori T; Yamabe H; Okuma M; Uchiyama T
    Blood; 1995 Sep; 86(6):2350-7. PubMed ID: 7662981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive overexpression of the L-selectin gene in fresh leukemic cells of adult T-cell leukemia that can be transactivated by human T-cell lymphotropic virus type 1 Tax.
    Tatewaki M; Yamaguchi K; Matsuoka M; Ishii T; Miyasaka M; Mori S; Takatsuki K; Watanabe T
    Blood; 1995 Oct; 86(8):3109-17. PubMed ID: 7579405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-I Tax trans-activation and cell growth signaling.
    Nakamura M; Takasawa N; Ohbo K; Higashimura N; Ohtani K; Tanaka Y; Sugamura K
    Leukemia; 1997 Apr; 11 Suppl 3():7-9. PubMed ID: 9209280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial transplantation of adult T cell leukemia cells into severe combined immunodeficient mice.
    Imada K; Takaori-Kondo A; Sawada H; Imura A; Kawamata S; Okuma M; Uchiyama T
    Jpn J Cancer Res; 1996 Sep; 87(9):887-92. PubMed ID: 8878449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling of gp34 (OX40 ligand) induces vascular endothelial cells to produce a CC chemokine RANTES/CCL5.
    Kotani A; Hori T; Matsumura Y; Uchiyama T
    Immunol Lett; 2002 Oct; 84(1):1-7. PubMed ID: 12161277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection.
    Takahashi Y; Tanaka Y; Yamashita A; Koyanagi Y; Nakamura M; Yamamoto N
    J Virol; 2001 Aug; 75(15):6748-57. PubMed ID: 11435553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of human T-cell leukemia virus type I T-cell lymphomas in severe combined immunodeficient mice.
    Feuer G; Zack JA; Harrington WJ; Valderama R; Rosenblatt JD; Wachsman W; Baird SM; Chen IS
    Blood; 1993 Aug; 82(3):722-31. PubMed ID: 8338942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of high levels of plasma OX40 with acute adult T-cell leukemia.
    Tanaka Y; Takahashi Y; Tanaka R; Miyagi T; Saito M; Fukushima T
    Int J Hematol; 2019 Mar; 109(3):319-327. PubMed ID: 30652238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-1 gene expression in adult T-cell leukemia cells elicits an NK cell response in vitro and correlates with cell rejection in SCID mice.
    Stewart SA; Feuer G; Jewett A; Lee FV; Bonavida B; Chen IS
    Virology; 1996 Dec; 226(2):167-75. PubMed ID: 8955035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model of in vivo cell proliferation of adult T-cell leukemia.
    Kondo A; Imada K; Hattori T; Yamabe H; Tanaka T; Miyasaka M; Okuma M; Uchiyama T
    Blood; 1993 Oct; 82(8):2501-9. PubMed ID: 8400297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong induction of ICAM-1 in human T cells transformed by human T-cell-leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell-leukemia-derived cell lines.
    Fukudome K; Furuse M; Fukuhara N; Orita S; Imai T; Takagi S; Nagira M; Hinuma Y; Yoshie O
    Int J Cancer; 1992 Sep; 52(3):418-27. PubMed ID: 1356935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.
    Dewan MZ; Terashima K; Taruishi M; Hasegawa H; Ito M; Tanaka Y; Mori N; Sata T; Koyanagi Y; Maeda M; Kubuki Y; Okayama A; Fujii M; Yamamoto N
    J Virol; 2003 May; 77(9):5286-94. PubMed ID: 12692230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SFA-1/PETA-3 (CD151), a member of the transmembrane 4 superfamily, associates preferentially with alpha 5 beta 1 integrin and regulates adhesion of human T cell leukemia virus type 1-infected T cells to fibronectin.
    Hasegawa H; Nomura T; Kishimoto K; Yanagisawa K; Fujita S
    J Immunol; 1998 Sep; 161(6):3087-95. PubMed ID: 9743375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.